Related Experiment Video
Updated: Mar 30, 2026
06:53
A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
Published on: July 9, 2020
5.7K
New Developments in Our Understanding of Neointimal Hyperplasia
1Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL; Birmingham Veterans Affairs Medical Center, Birmingham, AL; Section of Nephrology, Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudia Arabia.
Advances in Chronic Kidney Disease
|November 4, 2015
Summary
Vascular access failure in hemodialysis patients is often caused by venous stenosis due to neointimal hyperplasia. Novel therapies are being explored to combat this common cause of arteriovenous fistula and graft dysfunction.
Area of Science:
- Vascular Surgery
- Nephrology
- Pathology
Background:
- Vascular access is crucial for hemodialysis patients.
- Venous stenosis, characterized by neointimal hyperplasia, is a primary cause of vascular access dysfunction in arteriovenous fistulas and grafts.
- Understanding neointimal hyperplasia is key to improving vascular access outcomes.
Purpose of the Study:
- To review recent advancements in understanding the pathophysiology of neointimal hyperplasia in vascular access failure.
- To discuss atypical factors contributing to neointimal hyperplasia.
- To highlight novel therapies and future challenges in managing vascular access dysfunction.
Main Methods:
- Review of current literature on neointimal hyperplasia in vascular access.
- Analysis of pathological characteristics of stenotic lesions.
- Evaluation of clinical trial data for novel therapeutic interventions.
Main Results:
- Neointimal hyperplasia is a common histological finding in failing arteriovenous fistulas and grafts.
- Several novel therapies targeting neointimal hyperplasia have shown promise in clinical trials.
- Atypical factors can also contribute to neointimal hyperplasia development.
Conclusions:
- Improved understanding of neointimal hyperplasia pathophysiology is advancing treatment strategies.
- Novel therapies offer potential to improve vascular access longevity.
- Further research is needed to overcome challenges and translate findings into clinical practice.
Related Concept Videos
01:30Atherosclerosis I: Introduction
2.0K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.0K
01:22Mitral Stenosis I: Introduction
1.3K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
01:30Peripheral Artery Disease I: Introduction
610
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
610
01:21Myocarditis I: Introduction
574
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
574
01:10Mechanism of Angiogenesis
7.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.6K
01:26Coronary Artery Disease II: Pathophysiology
960
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
960